Korean J Hepatobiliary Pancreat Surg.  2014 Nov;18(4):105-111. 10.14701/kjhbps.2014.18.4.105.

Influence of metabolic and other clinicopathologic factors on the prognosis of patients with hepatocellular carcinoma undergoing hepatic resection

• Choi KS
• Kim DS
• Jung SW
• Yu YD
• Suh SO

• KMID: 1802224
• DOI: http://doi.org/10.14701/kjhbps.2014.18.4.105

Abstract

BACKGROUNDS/AIMS
The prognosis of hepatic resection for hepatocellular carcinoma (HCC) in patients with cirrhosis is worse than in those without cirrhosis. In Korea, the hepatitis B virus prevalence rate is higher than in other countries. Therefore, we investigated patients' clinicopathologic and metabolic factors that affect the postoperative outcomes of hepatic resection for HCC in our hospital in Korea.
METHODS
From August 2000 to December 2012, 171 HCC patients underwent hepatic resections at our institution. Two operative mortality cases and two short-term follow up cases were excluded. Data was collected from a retrospective chart review. There were 133 males (79.6%) and 34 females (20.3%), with a mean age of 58.2+/-10.2 years (range, 22-81 years), and the relationship between clinicopathologic and metabolic factors and the prognosis of patients with HCC undergoing hepatic resection were evaluated by univariate and multivariate analysis.
RESULTS
Hypertension, major surgery, perioperative transfusion, resection with radiofrequency ablation (RFA) or cryoablation, and resection margin were risk factors for overall survival, and hypertension, albumin, resection with RFA or cryoablation, perioperative transfusion, and tumor size were risk factors for disease-free survival.
CONCLUSIONS
We found that hypertension, perioperative transfusion, and resection with RFA or cryoablation were risk factors for both disease-free and overall survival after hepatic resection in HCC patients. Further study is required to clarify the influence of metabolic and other clinicopathologic factors on the prognosis of HCC.

Keyword

Hypertension; Hepatocellular carcinoma; Hepatic resection; Prognosis

MeSH Terms

Carcinoma, Hepatocellular*
Catheter Ablation
Cryosurgery
Disease-Free Survival
Female
Fibrosis
Follow-Up Studies
Hepatitis B virus
Humans
Hypertension
Korea
Male
Mortality
Multivariate Analysis
Prevalence
Prognosis*
Retrospective Studies
Risk Factors

Figure

• 

  Fig. 1 Disease-free survival curve of 157 patients (A) and overall survival curve of all patients (B).

• 

  Fig. 2 Comparison of overall survival curves according to hypertension.

• 

  Fig. 3 Comparison of disease-free survival curves according to hypertension.

Reference

1. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53:1020–1022. PMID: 21374666.

2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006; 43:S99–S112. PMID: 16447287.

3. Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009; 115:5651–5661. PMID: 19834957.

4. Kaibori M, Ishizaki M, Matsui K, Kitade H, Matsui Y, Kwon AH. Evaluation of metabolic factors on the prognosis of patients undergoing resection of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011; 26:536–543. PMID: 21332549.

5. Shimada M, Matsumata T, Akazawa K, Kamakura T, Itasaka H, Sugimachi K, et al. Estimation of risk of major complications after hepatic resection. Am J Surg. 1994; 167:399–403. PMID: 8179084.

6. Kim WW, Lee KW, Choi SH, Heo JS, Kim YI, Kim SJ, et al. Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma. Korean J Hepatol. 2004; 10:51–61. PMID: 15096717.

7. Abdel-Wahab M, El-Husseiny TS, El Hanafy E, El Shobary M, Hamdy E. Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbecks Arch Surg. 2010; 395:625–632. PMID: 20358380.

8. Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg. 1998; 85:195–198. PMID: 9501814.

9. Teoh NC, Fan JG. Diabetes mellitus and prognosis after curative therapy for hepatocellular carcinoma: alas, still grave for those who are hyperglycemic. J Gastroenterol Hepatol. 2008; 23:1633–1634. PMID: 19120856.

10. Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, et al. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol. 2003; 98:2293–2298. PMID: 14572582.

11. Yanaga K, Matsumata T, Hayashi H, Shimada M, Urata K, Suehiro T, et al. Effect of diabetes mellitus on hepatic resection. Arch Surg. 1993; 128:445–448. PMID: 8384436.

12. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, et al. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998; 27:1567–1571. PMID: 9620328.

13. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol. 2009; 8:13–20. PMID: 19221528.

14. Poon RT, Fan ST, Wong J. Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol. 2002; 97:1480–1488. PMID: 12094870.

15. Kaczynski J, Hansson G, Wallerstedt S. Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma. Dig Dis Sci. 2006; 51:796–802. PMID: 16615006.

16. Hu YF, Chen TC, Chau GY, Yang TL, Liu CJ, Chen MH, et al. Baseline hypertension: new insight into the potential predictors of survival in patients with hepatocellular carcinoma. Int J Cardiol. 2013; 168:2979–2981. PMID: 23659881.

17. Kubo S, Tanaka H, Shuto T, Takemura S, Yamamoto T, Kanazawa A, et al. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today. 2005; 35:216–222. PMID: 15772792.

18. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003; 237:536–543. PMID: 12677151.

19. Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg. 1999; 23:676–680. PMID: 10390585.

20. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001; 234:63–70. PMID: 11420484.

21. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg. 1987; 205:33–40. PMID: 3026259.

22. Zarzavadjian Le, Costi R, Constantinides V, Smadja C. Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. J Gastrointest Surg. 2012; 16:2247–2255. PMID: 23054903.

23. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002; 81:195–202. PMID: 12451624.